pneumonia

Postoperative pneumonia after cardiopulmonary bypass remains common and costly. In a prospective randomized proof-of-concept trial, high-dose inhaled nitric oxide was delivered perioperatively to prevent nosocomial infection. Feasibility and safety were dem...

After cardiopulmonary bypass, nosocomial pneumonia remains a frequent complication. High-dose nitric oxide was tested perioperatively as an adjunct to reduce infection via direct antimicrobial and mucociliary effects. Early signals indicate feasibility and ...

Nosocomial pneumonia remains a frequent complication after cardiopulmonary bypass. High-dose inhaled nitric oxide has antimicrobial and microcirculatory effects that could reduce early pulmonary infection. In a randomized, prospective proof-of-concept evalu...